Actively Recruiting
Safety Registry of a Fecal Microbiota Transplant Cohort
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-25
305
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clostridium difficile infection (CDI) is a major cause of infectious diarrhea and the most important cause of nosocomial diarrhea. Recurrent forms are a major problem with this infection. The use of fecal microbiota transplantation (FMT), FMT appears in the most recent European and North American recommendations. There is no cohort or multicenter registry in France prospectively collecting FMTs, the methods used, their efficacy and side effects. Likewise, there is no prospective collection focused on the cohort of stool donors. A large national cohort of patients who have undergone FMT as part of routine care as well as donors, is essential for evaluating the safety of FMT.
CONDITIONS
Official Title
Safety Registry of a Fecal Microbiota Transplant Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient with an indication for FMT for CDI (severe refractory CDI, recurrent CDI)
- Able to provide informed written consent
- Adult stool donors (18 years or older)
- Stool donors able to provide informed written consent
You will not qualify if you...
- Insufficient understanding of written and spoken French language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gastroenterology Department of Saint Antoine Hospital
Paris, France, 75012
Actively Recruiting
Research Team
H
Harry SOKOL, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here